BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Phenylpropanolamine

A sympathomimetic that acts mainly by causing release of NOREPINEPHRINE but also has direct agonist activity at some adrenergic receptors. It is most commonly used as a nasal vasoconstrictor and an appetite depressant.

300+ PubMed studies analyzed · 33 RCTs · Evidence Score: 45.5

Research Domains

Phenylpropanolamine has been studied across 17 research domains including ❤️ Cardiovascular, 🔥 Metabolic, 🧠 Focus & Attention, 🧘 Stress & Anxiety, 😴 Sleep. The primary research focus is ❤️ Cardiovascular with 29% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Phenylpropanolamine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

naftopidil
2 shared targets
cyclazosin
2 shared targets
bmy
2 shared targets
nan
2 shared targets
alfuzosin
2 shared targets
brimonidine
2 shared targets
corynantheine
2 shared targets
Piperoxan
2 shared targets
Methoxamine
2 shared targets
rauwolscine
2 shared targets
Loading evidence profile...

This evidence profile for Phenylpropanolamine is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.